De-risking Drug Development | Episode 1: How to drive value in pre-clinical development

De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial success.

In episode one we discuss the critical decision points in the pre-clinical phase that can ultimately determine the success of your product. Specifically, we consider how biotech sponsors should translate the science to clinical application and communicate this effectively to investors. We also explore the other key stakeholder groups where strategic communication planning should start early, and we focus on how including the patient perspective in the pre-clinical phase can impact commercial success. 

Return to Insights Center

Related Insights